No deviation in use of public and preferential issue proceeds
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the quarter and half-year ended 30 September 2026, Achyut Healthcare confirmed no deviation from the approved use of funds. The filing covers Rs 360 lakh raised through a public issue and preferential issues of Rs 520.80 lakh, Rs 1,572.48 lakh and Rs 348 lakh. Allocations remained aligned with the stated objects.
Neutral for shareholders: proceeds were used as approved, with no change in plans or diversion of funds.